Get the latest Science News and Discoveries

Engineered TYK2 dependence enables myeloid-selective IL-10 receptor agonism

A tetravalent nanobody-based myeloid-selective IL-10 receptor agonist recapitulates IL-10’s potent suppression of monocytes, macrophages and dendritic cells while avoiding stimulation of T cells.

None

Get the Android app